UKE – HCKH

The III. Department of Medicine at the University Medical Center Hamburg-Eppendorf is dedicated to the care of patients and to experimental and clinical kidney research with a number of national and international collaborations and internationally leading research programs aiming to identify mechanisms and new treatment options for various human kidney diseases. As part of PRIME CKD, the UKE is leading an international study validating analytical aspects relevant for the clinical measurement of biomarker-based tests to predict the response of patients with CKD to existing drugs.

People involved in Prime-CKD

Tobias B Huber (Prof., MD)

Chair of the Center of Internal Medicine, UKE, Hamburg, Germany
Director of the III. Department of Medicine, UKE, Hamburg, Germany
Project Leader WP1/ Clinical Head

Maja Lindenmeyer (PD, PhD)

Laboratory Head/Head OF Biobank at the III. Department of Medicine, UKE, Hamburg, Germany
Deputy Study Coordinator UVALID Study

Elisabeth Meister (MD)

Clinician scientist at the III. Department of Medicine, UKE, Hamburg, Germany
Study Coordinator UVALID Study

UKE – HCKH

People involved in Prime-CKD

Tobias B Huber (Prof., MD)

Maja Lindenmeyer (PD, PhD)

Elisabeth Meister (MD)

Links

EU FUNDING

CONTACT